{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:45:35Z","timestamp":1790783135494,"version":"4.1.0"},"reference-count":36,"publisher":"American Society for Clinical Investigation","issue":"20","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"crossref","award":["R01AI152044,R35GM127027,R01GM137203"],"award-info":[{"award-number":["R01AI152044,R35GM127027,R01GM137203"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,24]]},"abstract":"<jats:p>\n                    Peritoneal metastases are associated with a low response rate to immune checkpoint blockade (ICB) therapy. The numbers of peritoneal resident macrophages (PRMs) are reversely correlated with the response rate to ICB therapy. We have previously shown that TLR9 in fibroblastic reticular cells (FRCs) plays a critical role in regulating peritoneal immune cell recruitment. However, the role of TLR9 in FRCs in regulating PRMs is unclear. Here, we demonstrated that the class A TLR9 agonist, ODN1585, markedly enhanced the efficacy of anti\u2013PD-1 therapy in mouse models of colorectal peritoneal metastases. ODN1585 injected i.p. reduced the numbers of Tim4\n                    <jats:sup>+<\/jats:sup>\n                    PRMs and enhanced CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell antitumor immunity. Mechanistically, treatment of ODN1585 suppressed the expression of genes required for retinoid metabolism in FRCs, and this was associated with reduced expression of the PRM lineage\u2013defining transcription factor GATA6. Selective deletion of TLR9 in FRCs diminished the benefit of ODN1585 in anti\u2013PD-1 therapy in reducing peritoneal metastases. The crosstalk between PRMs and FRCs may be utilized to develop new strategies to improve the efficacy of ICB therapy for peritoneal metastases.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.160063","type":"journal-article","created":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T14:00:56Z","timestamp":1666533656000},"source":"Crossref","is-referenced-by-count":12,"title":["Intraperitoneal injection of class A TLR9 agonist enhances anti\u2013PD-1 immunotherapy in colorectal peritoneal metastases"],"prefix":"10.1172","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9757-7441","authenticated-orcid":true,"given":"Ting","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA."},{"name":"Tsinghua University School of Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7704-4365","authenticated-orcid":true,"given":"Hongji","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University, Columbus, Ohio, USA."},{"name":"Department of Surgery, University of Virginia, Charlottesville, Virginia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4961-6370","authenticated-orcid":true,"given":"Preethi","family":"Jayakumar","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University, Columbus, Ohio, USA."},{"name":"Center for Immunology and Inflammation, Feinstein Institutes for Medical Research, Manhasset, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7430-0119","authenticated-orcid":true,"given":"Hai","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University, Columbus, Ohio, USA."},{"name":"Center for Immunology and Inflammation, Feinstein Institutes for Medical Research, Manhasset, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Billiar","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1901-347X","authenticated-orcid":true,"given":"Meihong","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University, Columbus, Ohio, USA."},{"name":"Center for Immunology and Inflammation, Feinstein Institutes for Medical Research, Manhasset, New York, USA."},{"name":"Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2019.12.008"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.31787"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191869"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.141115"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.05.006"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010060"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002195"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.009"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.06.010"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe0595"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27614-9"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3734"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.10.007"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00144-3"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002876"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000940"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI127542"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2016-0006"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.05.010"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.04.016"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2684"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182024"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1251414"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI127286"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2011.08.002"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75844-6"},{"issue":"1","key":"B27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jviscsurg.2021.09.005","article-title":"Peritoneal recurrence of colorectal cancer with microsatellite instability: is immunotherapy alone more effective than surgery?","volume":"159","author":"Gavignet","year":"2021","journal-title":"J Visc Surg"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.09.020"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30787-x"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1242974"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11852"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.866993"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83885"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aar4539"},{"issue":"361","key":"B35","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005548","article-title":"Shedding of the tumor necrosis factor (TNF) receptor from the surface of hepatocytes during sepsis limits inflammation through cGMP signaling","volume":"8","author":"Deng","year":"2015","journal-title":"Sci Signal"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215333"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/160063\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:28:09Z","timestamp":1779146889000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/160063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":36,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022,10,24]]},"published-print":{"date-parts":[[2022,10,24]]}},"alternative-id":["10.1172\/jci.insight.160063"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.160063","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"article-number":"e160063"}}